Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

[Pulmonary Epithelial Hemangioendothelioma Needed to Differentiate from Metastatic Lung Tumor;Report of a Case].

Hirano F, Marui T, Murakawa S, Matsumoto S.

Kyobu Geka. 2019 Apr;72(4):321-323. Japanese.

PMID:
31266919
2.

Comparison of fluorescence optical imaging, ultrasonography and clinical examination with magnetic resonance imaging as a reference in active rheumatoid arthritis patients.

Hirano F, Yokoyama-Kokuryo W, Yamazaki H, Tsutsumino M, Sakai R, Satoh S, Kimura T, Tojo N, Kohsaka H, Harigai M.

Immunol Med. 2018 Jun;41(2):75-81. doi: 10.1080/13497413.2018.1481578. Epub 2018 Sep 7.

PMID:
30938268
3.

Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.

Namba N, Kawasaki A, Sada KE, Hirano F, Kobayashi S, Yamada H, Furukawa H, Shimada K, Hashimoto A, Matsui T, Nagasaka K, Sugihara T, Suzuki A, Yamagata K, Sumida T, Tohma S, Homma S, Ozaki S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS).

Ann Rheum Dis. 2019 Aug;78(8):1144-1146. doi: 10.1136/annrheumdis-2018-214263. Epub 2019 Feb 14. No abstract available.

PMID:
30765393
4.

Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients.

Matsumoto T, Matsui T, Hirano F, Tohma S, Mori M.

Mod Rheumatol. 2018 Nov 30:1-15. doi: 10.1080/14397595.2018.1554228. [Epub ahead of print]

PMID:
30499364
5.

No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.

Sakai R, Kasai S, Hirano F, Harada S, Kihara M, Yokoyama W, Tsutsumino M, Nagasaka K, Koike R, Yamanaka H, Miyasaka N, Harigai M.

Int J Rheum Dis. 2018 Sep;21(9):1670-1677. doi: 10.1111/1756-185X.13300. Epub 2018 Apr 17.

PMID:
29667330
6.

Survey of the awareness of adult rheumatologists regarding transitional care for patients with juvenile idiopathic arthritis in Japan.

Matsui T, Matsumoto T, Hirano F, Tokunaga F, Okamoto K, Tohma S, Morio T, Kohsaka H, Mori M.

Mod Rheumatol. 2018 Nov;28(6):981-985. doi: 10.1080/14397595.2018.1430546. Epub 2018 Feb 8.

PMID:
29347862
7.

Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.

Kawasaki A, Yamashita K, Hirano F, Sada KE, Tsukui D, Kondo Y, Kimura Y, Asako K, Kobayashi S, Yamada H, Furukawa H, Nagasaka K, Sugihara T, Yamagata K, Sumida T, Tohma S, Kono H, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.

J Hum Genet. 2018 Jan;63(1):55-62. doi: 10.1038/s10038-017-0362-2. Epub 2017 Oct 5.

PMID:
29167552
8.

Aneurysm formation after stent grafting in vascular Behçet's disease.

Honda S, Hirano F, Mouri M, Hasegawa H, Kohsaka H.

Arthritis Rheumatol. 2018 Feb;70(2):322. doi: 10.1002/art.40337. No abstract available.

9.

Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.

Harada S, Sakai R, Hirano F, Miyasaka N, Harigai M; REAL Study Group.

J Rheumatol. 2017 Jul;44(7):988-995. doi: 10.3899/jrheum.161196. Epub 2017 Apr 15.

PMID:
28412701
10.

The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.

Izumi Y, Akazawa M, Akeda Y, Tohma S, Hirano F, Ideguchi H, Matsumura R, Miyamura T, Mori S, Fukui T, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Sugiyama T, Suenaga Y, Okada Y, Katayama M, Ichikawa K, Furukawa H, Kawakami K, Oishi K, Migita K.

Arthritis Res Ther. 2017 Jan 25;19(1):15. doi: 10.1186/s13075-016-1207-7.

11.

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.

Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H, Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Tomita M, Kihara M, Yokoyama W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Kohsaka H, Miyasaka N, Harigai M.

Arthritis Res Ther. 2017 Jan 18;19(1):7. doi: 10.1186/s13075-016-1206-8.

12.

Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy.

Hirano F, Yokoyama W, Yamazaki H, Amano K, Kawakami A, Hayashi T, Tamura N, Yasuda S, Dobashi H, Fujii T, Ito S, Kaneko Y, Matsui T, Okuda Y, Saito K, Suzuki F, Yoshimi R, Sakai R, Koike R, Kohsaka H, Miyasaka N, Harigai M; T2T Epidemiological Study Group.

Mod Rheumatol. 2017 Sep;27(5):811-819. doi: 10.1080/14397595.2016.1265726. Epub 2016 Dec 21.

PMID:
27919205
13.

Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.

Yamazaki H, Hirano F, Takeuchi T, Amano K, Kikuchi J, Kihara M, Yokoyama W, Sugihara T, Nagasaka K, Hagiyama H, Nonomura Y, Sakai R, Tanaka M, Koike R, Nanki T, Kohsaka H, Miyasaka N, Harigai M.

Mod Rheumatol. 2017 Sep;27(5):787-794. doi: 10.1080/14397595.2016.1259715. Epub 2016 Dec 15.

PMID:
27846756
14.

Pathogenic characterization of Erysipelothrix rhusiopathiae Met-203 type SpaA strains from chronic and subacute swine erysipelas in Japan.

Uchiyama M, Shimazaki Y, Isshiki Y, Kojima A, Hirano F, Yamamoto K, Kijima M, Nagai H.

J Vet Med Sci. 2017 Jan 20;79(1):18-21. doi: 10.1292/jvms.16-0164. Epub 2016 Oct 21.

15.

Study of Atypical Femoral Fracture Cases Coupled in a Multicenter Study.

Zenke Y, Ikeda S, Fukuda F, Tanaka M, Tanaka H, Hirano F, Sakai A.

J UOEH. 2016 Sep;38(3):207-14. doi: 10.7888/juoeh.38.207.

16.

Epidemiological study of adult-onset Still's disease using a Japanese administrative database.

Sakata N, Shimizu S, Hirano F, Fushimi K.

Rheumatol Int. 2016 Oct;36(10):1399-405. doi: 10.1007/s00296-016-3546-8. Epub 2016 Aug 9.

PMID:
27502500
17.

Establishment of an equine tetanus antitoxin reference standard for veterinary use in Japan.

Hirano F, Imamura S, Sasaki Y, Takikawa N, Sawata A, Yamamoto A, Uchiyama M, Shimazaki Y, Kojima A, Nagai H.

Biologicals. 2016 Sep;44(5):374-7. doi: 10.1016/j.biologicals.2016.06.008. Epub 2016 Jul 22.

PMID:
27461125
18.

Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.

Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H, Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.

PLoS One. 2016 May 11;11(5):e0154393. doi: 10.1371/journal.pone.0154393. eCollection 2016.

19.

Tacrolimus successfully used to control refractory eosinophilic granulomatosis with polyangiitis complicated by invasive aspergillosis and chronic hepatitis B.

Hirano F, Mizoguchi F, Harigai M, Miyasaka N, Kohsaka H.

Int J Rheum Dis. 2019 Apr;22(4):746-749. doi: 10.1111/1756-185X.12869. Epub 2016 Apr 29.

PMID:
27125472
20.

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Kitagawa K, Takahi K, Ozawa T, Hamada N, Nakajima K, Nagai H, Tamura N, Suenaga Y, Kawabata M, Matsui T, Furukawa H, Kawakami K, Oishi K.

Medicine (Baltimore). 2015 Dec;94(52):e2184. doi: 10.1097/MD.0000000000002184. Erratum in: Medicine (Baltimore). 2016 Feb;95(8):e8362. Oish, Kazunori [Corrected to Oishi, Kazunori].

21.

High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.

Sakai R, Hirano F, Kihara M, Yokoyama W, Yamazaki H, Harada S, Nanki T, Koike R, Miyasaka N, Harigai M.

Mod Rheumatol. 2016 Jul;26(4):522-8. doi: 10.3109/14397595.2015.1106682. Epub 2015 Dec 14.

PMID:
26666766
22.

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Dec 10;17:357. doi: 10.1186/s13075-015-0863-3.

23.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Sugiyama T, Kawabe Y, Katayama M, Suenaga Y, Okamoto A, Ohshima H, Okada Y, Ichikawa K, Yoshizawa S, Kawakami K, Matsui T, Furukawa H, Oishi K.

Arthritis Res Ther. 2015 Jun 3;17:149. doi: 10.1186/s13075-015-0662-x.

24.

Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).

Sugihara T, Ishizaki T, Hosoya T, Iga S, Yokoyama W, Hirano F, Miyasaka N, Harigai M.

Rheumatology (Oxford). 2015 May;54(5):798-807. doi: 10.1093/rheumatology/keu395. Epub 2014 Oct 8.

PMID:
25296748
25.

Development of a serology-based assay for efficacy evaluation of a lactococcicosis vaccine in Seriola fish.

Nakajima N, Kawanishi M, Imamura S, Hirano F, Uchiyama M, Yamamoto K, Nagai H, Futami K, Katagiri T, Maita M, Kijima M.

Fish Shellfish Immunol. 2014 May;38(1):135-9. doi: 10.1016/j.fsi.2014.03.013. Epub 2014 Mar 20.

PMID:
24657319
26.

Prevalence of Met-203 type spaA variant in Erysipelothrix rhusiopathiae isolates and the efficacy of swine erysipelas vaccines in Japan.

Uchiyama M, Yamamoto K, Ochiai M, Yamamoto T, Hirano F, Imamura S, Nagai H, Ohishi K, Horiuchi N, Kijima M.

Biologicals. 2014 Mar;42(2):109-13. doi: 10.1016/j.biologicals.2013.12.002. Epub 2014 Jan 7.

PMID:
24405986
27.

Development of an in vitro assay based on humoral immunity for quality control of oil-adjuvant Pseudotuberculosis vaccine in Yellowtail Seriola quinqueradiata.

Hirano F, Imamura S, Nakajima N, Yamamoto K, Uchiyama M, Nagai H, Kijima M.

Biologicals. 2014 Jan;42(1):48-51. doi: 10.1016/j.biologicals.2013.11.004. Epub 2013 Dec 8.

PMID:
24325870
28.

Prevalence of staphylococcal enterotoxins in Staphylococcus pseudintermedius isolates from dogs with pyoderma and healthy dogs.

Tanabe T, Toyoguchi M, Hirano F, Chiba M, Onuma K, Sato H.

Microbiol Immunol. 2013 Sep;57(9):651-4. doi: 10.1111/1348-0421.12069.

29.

Bovine whole-blood culture as a tool for the measurement of endotoxin activities in Gram-negative bacterial vaccines.

Imamura S, Nakamizo M, Kawanishi M, Nakajima N, Yamamoto K, Uchiyama M, Hirano F, Nagai H, Kijima M, Ikebuchi R, Mekata H, Murata S, Konnai S, Ohashi K.

Vet Immunol Immunopathol. 2013 May 15;153(1-2):153-8. doi: 10.1016/j.vetimm.2013.02.002. Epub 2013 Feb 8.

PMID:
23465356
30.

Breast arterial calcification and hypertension associated with vertebral fracture.

Wada H, Hirano F, Kuroda T, Shiraki M.

Geriatr Gerontol Int. 2012 Apr;12(2):330-5. doi: 10.1111/j.1447-0594.2011.00775.x. Epub 2011 Nov 28.

PMID:
22122503
31.

[Case report; mycotic aneurysm caused by Listeria monocytogenes].

Otowa T, Hirano F, Ashihara J, Ura N.

Nihon Naika Gakkai Zasshi. 2011 Apr 10;100(4):1048-50. Japanese. No abstract available.

PMID:
21626843
32.

Autologous extracellular cytochrome c is an endogenous ligand for leucine-rich alpha2-glycoprotein and beta-type phospholipase A2 inhibitor.

Shirai R, Gotou R, Hirano F, Ikeda K, Inoue S.

J Biol Chem. 2010 Jul 9;285(28):21607-14. doi: 10.1074/jbc.M110.122788. Epub 2010 May 4.

33.

Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response.

Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S.

Biochem Biophys Res Commun. 2009 May 15;382(4):776-9. doi: 10.1016/j.bbrc.2009.03.104. Epub 2009 Mar 24.

PMID:
19324010
34.

Homeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activity.

Takahashi K, Hirano F, Matsumoto K, Aso K, Haneda M.

Pancreas. 2009 Jan;38(1):49-57. doi: 10.1097/MPA.0b013e31817fa2ba.

PMID:
19106744
35.

Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.

Hirano F, Haneda M, Makino I.

J Gastroenterol Hepatol. 2006 Dec;21(12):1807-13.

PMID:
17074018
36.

The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells.

Kobayashi A, Hirano F, Makino I.

Scand J Rheumatol. 2005 Nov-Dec;34(6):480-4.

PMID:
16393773
37.

Research on leachate recirculation from different types of landfills.

Wang Q, Matsufuji Y, Dong L, Huang Q, Hirano F, Tanaka A.

Waste Manag. 2006;26(8):815-24.

PMID:
16321514
38.

Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.

Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M, Rietz C, Flies DB, Lau JS, Zhu G, Tamada K, Chen L.

Cancer Res. 2005 Feb 1;65(3):1089-96.

39.

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.

Luo L, Chapoval AI, Flies DB, Zhu G, Hirano F, Wang S, Lau JS, Dong H, Tamada K, Flies AS, Liu Y, Chen L.

J Immunol. 2004 Nov 1;173(9):5445-50.

40.
41.

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K, Salomao D, Cheville J, Hirano F, Lin W, Kasperbauer JL, Ballman KV, Chen L.

Cancer Res. 2003 Oct 1;63(19):6501-5.

42.

[Thrombotic thrombocytopenic purpura developing during pregnancy in a patient with systemic lupus erythematosus].

Komura K, Nomura Y, Takahashi K, Ishizeki K, Kobayashi A, Hirano Y, Fukawa E, Hirano F, Makino I.

Nihon Naika Gakkai Zasshi. 2003 Jul 10;92(7):1333-6. Japanese. No abstract available.

PMID:
12924283
43.

Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.

Yamamoto K, Iwahana M, Kumazawa E, Kakihata K, Abe K, Hirano F, Tohgo A, Hoshiai H, Noda K.

Oncol Rep. 2003 May-Jun;10(3):593-8.

PMID:
12684629
45.
46.

Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts.

Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I.

Ann Rheum Dis. 2002 Sep;61(9):834-7.

47.

Fibrates suppress chenodeoxycholic acid-induced RANTES expression through inhibition of NF-kappaB activation.

Hirano Y, Hirano F, Fujii H, Makino I.

Eur J Pharmacol. 2002 Jul 12;448(1):19-26.

PMID:
12126966
48.

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L.

Nat Med. 2002 Aug;8(8):793-800. Epub 2002 Jun 24. Erratum in: Nat Med 2002 Sep;8(9):1039.

PMID:
12091876
49.

[Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].

Akiyoshi M, Shigeoka T, Torii S, Maki E, Enomoto S, Takahashi H, Hirano F.

Nihon Yakurigaku Zasshi. 2002 Mar;119(3):175-84. Review. Japanese.

PMID:
11915520
50.

Nuclear factor-κB regulates RANTES chemokine expression in response to tumor necrosis factor-α in fibroblast-like synoviocytes.

Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I.

Mod Rheumatol. 2002 Mar;12(1):37-43. doi: 10.3109/s101650200006.

PMID:
24383830

Supplemental Content

Loading ...
Support Center